COMPUGROUP Financial Statements From 2010 to 2024
| COPA Stock | EUR 20.80 0.20 0.97% |
Check COMPUGROUP MEDSPADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among COMPUGROUP MEDSPADR's main balance sheet or income statement drivers, such as , as well as many indicators such as . COMPUGROUP financial statements analysis is a perfect complement when working with COMPUGROUP MEDSPADR Valuation or Volatility modules.
COMPUGROUP |
COMPUGROUP MEDSPADR 1 Company Operating Margin Analysis
COMPUGROUP MEDSPADR's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current COMPUGROUP MEDSPADR Operating Margin | 0.08 % |
Most of COMPUGROUP MEDSPADR's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COMPUGROUP MEDSPADR 1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, COMPUGROUP MEDSPADR 1 has an Operating Margin of 0.0821%. This is 100.23% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The operating margin for all Germany stocks is 101.49% lower than that of the firm.
COMPUGROUP MEDSPADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining COMPUGROUP MEDSPADR's current stock value. Our valuation model uses many indicators to compare COMPUGROUP MEDSPADR value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across COMPUGROUP MEDSPADR competition to find correlations between indicators driving COMPUGROUP MEDSPADR's intrinsic value. More Info.COMPUGROUP MEDSPADR 1 is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for COMPUGROUP MEDSPADR 1 is roughly 3.61 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the COMPUGROUP MEDSPADR's earnings, one of the primary drivers of an investment's value.About COMPUGROUP MEDSPADR Financial Statements
COMPUGROUP MEDSPADR stakeholders use historical fundamental indicators, such as COMPUGROUP MEDSPADR's revenue or net income, to determine how well the company is positioned to perform in the future. Although COMPUGROUP MEDSPADR investors may analyze each financial statement separately, they are all interrelated. For example, changes in COMPUGROUP MEDSPADR's assets and liabilities are reflected in the revenues and expenses on COMPUGROUP MEDSPADR's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in COMPUGROUP MEDSPADR 1. Please read more on our technical analysis and fundamental analysis pages.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. COMPUGROUP MED is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.